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Based on potential benefits to human health, there is increasing interest in altering the composition of ruminant-derived foods.
Including rapeseeds in the dairy cow diet is an effective strategy for replacing medium-chain saturated fatty acids (SFA) with cis-
monounsaturated fatty acids (MUFA) in bovine milk, but there is limited information on the optimum level of supplementation.
Decreases in SFA due to plant oils are also accompanied by increases in milk trans fatty acid (FA) content and it is possible that
high oleic acid rapeseeds may result in a higher enrichment of cis-9 18:1 and lower increases in trans FAs in milk compared with
conventional varieties. Seven multiparous lactating Holstein–Friesian cows were allocated to one of seven treatments in an
incomplete Latin square design with five 28-day experimental periods, to evaluate the effect of replacing calcium salts of palm oil
distillate (CPO; 41 g/kg diet dry matter, DM) with 128, 168 or 207 g/kg diet DM of conventional (COR) or a high oleic acid (HOR)
rapeseed fed as a supplement milled with wheat. Rapeseed variety and inclusion level had no effect ( P. 0.05) on DM intake,
milk yield and composition. Both rapeseed varieties decreased linearly ( P, 0.001) milk fat SFA content, which was partially
compensated for by a linear increase ( P, 0.001) in cis-9 18:1 concentration. Reductions in milk SFA were also associated with
increases ( P, 0.05) in trans 18:1 and total trans FA content, with no difference ( P. 0.05) between rapeseed varieties. Replacing
CPO in the diet with milled rapeseeds had no effect (P. 0.05) on total milk conjugated linoleic acid (CLA) concentration. Relative to a
COR, inclusion of a high oleic acid variant in the diet increased ( P5 0.01) the ratio of trans-MUFA : trans-polyunsaturated fatty acids
in milk that may have implications with respect to cardiovascular disease risk in humans. In conclusion, data indicated that replacing
CPO with milled rapeseeds at levels up to 1150 g oil/day could be used as a nutritional strategy to lower milk SFA content without
inducing adverse effects on DM intake and milk production. HOR reduced milk fat SFA content to a greater extent than a
conventional variety, but did not minimise associated increases in trans FA concentrations. However, the high oleic acid variant did
alter the relative abundance of specific trans 18:1, CLA and trans 18:2 isomers compared with conventional rapeseeds.
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Implications
Certain saturated fatty acids (SFA) are thought to increase
the risk of cardiovascular disease (CVD). Milk and dairy
products are a major source of SFA in the human diet in
Europe, and therefore research has been directed towards
developing sustainable strategies to decrease milk fat SFA
content. This study examined the effect of inclusion level and
rapeseed type on milk fatty acid (FA) composition and dairy
cow performance. The results showed that replacing calcium
salts of palm oil distillate with rapeseed supplements altered
milk FA composition without adverse effects on milk produc-
tion. Inclusion of milled rapeseeds in the diet of lactating cows
could be used as part of an overall strategy for decreasing SFA
in the human diet with potential to lower CVD risk.
Introduction
Clinical and biomedical studies have shown that cardio-
vascular disease (CVD) risk factors can be improved by the
isoenergetic replacement of saturated fatty acids (SFA) with- E-mail: k.e.kliem@reading.ac.uk
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cis-monounsaturated fatty acids (MUFA) in the human diet
(Kris-Etherton et al., 1999; Mensink et al., 2003). Milk and
dairy products are the major source of SFA in the European
diet (Hulshof et al., 1999; Henderson et al., 2003). Rather
than simply advocating population-wide decreases in milk
and dairy product consumption, altering the FA composition
of ruminant milk offers the opportunity to lower SFA intake
while maintaining the contribution of these foods to high-
quality protein, bioactive lipid, mineral and vitamin supply in
the human diet (Shingfield et al., 2008).
Numerous studies have shown the potential of oilseed
and plant oil supplements in the diet to alter bovine milk FA
composition (Glasser et al., 2008; Shingfield et al., 2008). A
recent review reported an average decrease in total SFA
concentration in milk fat of almost 10 g/100 g FAs when
cows consume just over 500 g rapeseed oil/day (average
response from a number of studies; Glasser et al., 2008).
Larger decreases in SFA of almost 20 g/100 g of total FAs
have been reported in milk from cows fed diets supple-
mented with 4.1 kg/day of crushed rapeseeds supplying
1.97 kg of rapeseed oil, but the changes in milk fat compo-
sition were accompanied by substantial reductions in nutri-
ent intake and milk yield relative to the control diet (Givens
et al., 2003). Feeding high levels of supplemental fat to dairy
cows can adversely affect rumen function and lower milk
production (Palmquist, 1994; Lock and Shingfield, 2004).
Givens et al. (2009) concluded that rapeseed milled with
wheat, which offers a practical solution for processing oil-
seeds on-farm with the added benefit of minimising oil losses
during milling, represented the most ideal compromise for
lowering milk fat SFA content and increasing cis-MUFA
concentrations without affecting animal performance and
minimising associated increases in milk fat trans FAs.
Including rapeseed-based supplements in the diet of lac-
tating cows also increases milk trans FA concentrations (Loor
et al., 2002; Rego et al., 2009). Although some evidence
suggests that trans FAs from ruminant-derived products
may not exert as negative an effect on CVD risk as those
from industrial sources (Jakobsen et al., 2006; Willett and
Mozaffarian, 2008), other evidence is inconsistent (Shingfield
et al., 2008; Brouwer et al., 2010). Several varieties of
rapeseed containing higher proportions of oleic acid and
lower amounts of polyunsaturated fatty acids (PUFA) have
been bred and commercialised primarily for use as industrial
frying oils (Schierholt et al., 2000 and 2001). High oleic acid
rapeseed variants offer the potential to lower milk SFA
content, enhance cis-9 18:1 concentrations and minimise
increases in trans FAs compared with conventional rape-
seeds. The apparent biohydrogenation of cis-9 18:1 in the
rumen is not as high as that of 18:2n-6 and 18:3n-3
(Shingfield et al., 2010) with the implication that high oleic
acid variants would result in a greater proportion of dietary
unsaturated FAs escaping the rumen compared with con-
ventional rapeseeds. Furthermore, studies in grazing cows
have shown that increases in milk trans FA concentrations
due to plant oils are directly related to the ratio of PUFA : cis-
9 18:1 in lipid supplements (Rego et al., 2009), with the
implication that oilseeds rich in cis-9 18:1 rather than PUFA
would minimise the appearance of ruminal biohydrogena-
tion intermediates in milk fat triacylglycerides.
Previous studies have examined the effects of high oleic
acid rapeseed oil on milk fat composition (Jenkins, 1998;
Loor et al., 2002), but direct comparisons with conventional
sources of rapeseed oil have not been reported. In addition,
relatively few studies (Collomb et al., 2004; Givens et al.,
2009; Rego et al., 2009) have examined the effect of dietary
rapeseed inclusion on milk FA composition in sufficient detail
to allow definitive conclusions on the impact of the dis-
tribution of trans FA isomers to be drawn. In this experiment,
nutrient intake, milk production and milk FA composition
responses to replacing calcium salts of palm oil distillate
(CPO) with incremental amounts of milled conventional or
high oleic acid rapeseeds were evaluated in high-yielding
lactating cows fed maize silage-based diets.
Material and methods
Experimental design, animals and management
A total of seven multiparous Holstein–Friesian cows of
(mean6 s.e.) live weight 6336 18.3 kg, parity 5.66 0.53,
796 7.9 days in lactation and producing 44.76 1.39 kg
milk/day were used. Animals were randomly allocated to one
of seven treatments in an incomplete 73 7 Latin square
design with five 28-day experimental periods (Table 1). Cows
were housed in individual tie stalls equipped with a rubber
mattress and bedded with wood shavings. Clean water
and trace mineralised blocks (Rockies (red), Tithebarn Ltd,
Cheshire, UK) were available ad libitum. Cows were milked
in situ at 0400 and 1600 h.
Experimental diets
Diets were offered as total mixed rations (TMR; forage :
concentrate ratio, 50 : 50 on a dry matter (DM) basis with the
forage component consisting of maize silage and grass silage,
750 and 250 g/kg of forage DM, respectively). Treatments
consisted of a control diet containing 41 g/kg DM of CPO
(MegalacR , Volac International Ltd, Royston, UK) or the same
Table 1 Allocation of experimental treatments according to an
incomplete 73 7 Latin square design
Period
Cow 1 2 3 4 5
1 COR2 HOR2 COR3 CPO COR1
2 HOR3 COR1 HOR2 COR3 HOR1
3 HOR2 HOR1 CPO COR1 COR3
4 COR3 CPO HOR3 HOR1 COR2
5 HOR1 HOR3 COR2 HOR2 CPO
6 CPO COR2 COR1 HOR3 HOR2
7 COR1 COR3 HOR1 COR2 HOR3
COR1, COR2 and COR35 conventional oleic acid rapeseed at three inclusion
levels; HOR1, HOR2 and HOR35 high oleic acid rapeseed at three inclusion
levels; CPO5 calcium salts of palm oil distillate-based diet.
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basal diet with CPO replaced by 35, 46 or 57 g/kg DM of lipid
derived from two different rapeseed varieties milled with
wheat. Wheat was used as a binding agent to facilitate the
milling of rapeseeds and also prevent oil losses following the
rupturing of the seed coat. The milled rapeseed blend was
prepared by processing the whole seeds with wheat grain
(50 : 50, fresh weight basis) in a machine, which uses a
combination of hammer (12 mm) and roller mills (processor
model AFM 998Q; Buschhoft, GmbH & Co, Ahlen, Germany).
Rapeseed treatments were comprised of a mixture of
conventional varieties (Mozart and Astrid; COR) or a high oleic
acid rapeseed (Nexera 160; Dow AgroSciences LLC, Hitchin,
UK) variant. Diets were formulated to be isoenergetic and
isonitrogenous (Thomas, 2004) and supply 750, 1000 or
1250 g rapeseed oil/day assuming a predicted mean DM
intake of 22 kg/day. Ingredients and chemical composition of
the experimental diets are shown in Table 2. Cows were
offered diets as equal meals at 0830 and 1600 h. Feed refusals
were removed and weighed before the morning milking.
Experimental measurements, sample collection
and chemical analysis
Individual animal dietary intake was recorded daily. Samples
of fresh TMR, subsamples of individual dietary components
and refused feeds were collected daily during each sampling
week, and pooled to provide weekly composite samples.
Composite feed samples were stored at2188C until analysed
for chemical composition. Oven-dried (608C), milled (1 mm
screen) samples of forages, concentrates, conventional and
high oleic acid rapeseed/wheat mixes were submitted for
Table 2 Ingredients and chemical composition of experimental diets (g/kg DM or as stated)
Treatments1
CPO COR1 COR2 COR3 HOR1 HOR2 HOR3
Ingredients
Maize silage 373 375 375 375 375 375 375
Grass silage 124 125 125 125 125 125 125
Wheat straw 10 10 10 10 10 10 10
Milled rapeseed/wheat2 0 127.8 168 206.5 127.8 168 206.5
CPO3 41 0 0 0 0 0 0
Rapeseed meal 77 49 21.2 0 77 49 21.2
Soyabean meal 72 60 74.8 84 60 74.8 84
Sugar beet feed (molassed) 90 80 80 80 80 80 80
Milled wheat 91 68.2 41 14.5 68.2 41 14.5
Wheat feed4 15 20 20 20 20 20 20
Maize gluten meal 20 20 20 20 20 20 20
Soyabean hulls 45 20 20 20 20 20 20
Calcined magnesite 7 10 10 10 10 10 10
Minerals and vitamins5 15 15 15 15 15 15 15
Blended molasses and urea6 20 20 20 20 20 20 20
Chemical composition
DM (g/kg fresh) 595 594 595 595 594 596 596
CP 150 153 160 153 154 161 154
NDF 368 370 358 357 366 354 351
Starch 145 169 160 165 167 157 161
Water-soluble carbohydrates 37 35 32 35 37 34 38
ME (MJ/kg DM) 11.3 11.6 11.9 12.2 11.6 12.0 12.3
Fatty acids
16:0 16.2 3.9 4.1 4.5 3.6 3.8 4.1
18:0 1.54 0.81 0.95 1.11 0.81 0.95 1.10
18:1 cis-9 14.6 19.8 24.6 29.4 23.6 29.5 35.5
18:2n-6 10.3 12.9 14.2 15.8 11.7 12.6 13.8
18:3n-3 1.8 4.1 4.8 5.5 2.3 2.4 2.6
Total fatty acids 48 46 54 62 47 55 63
DM5 dry matter; CPO5 calcium salts of palm oil distillate; COR1, COR2 and COR35 conventional oleic acid rapeseed; HOR1, HOR2 and HOR35 high oleic acid
rapeseed; ME5metabolisable energy.
11, 2 and 3, rapeseed inclusion levels of 73, 96 and 118 g/kg DM, respectively.
2Added as a single mixture.
3MegalacR (Volac International Ltd, Royston, UK) declared composition (g/kg DM) as containing oil (840), calcium (90) and ME 33.25 MJ/kg DM.
4Wheat feed (GP Feeds Ltd, Cheshire, UK) declared composition (g/kg DM) as containing CP (175), NDF (400), starch and sugars (340) and ME 11.5 MJ/kg DM.
5Proprietary mineral and vitamin supplement (Rockies (Red), Tithebarn Ltd, Cheshire, UK) declared composition as containing 380 g/kg sodium and (mg/kg)
magnesium (5000), iron (1500), cobalt (50), copper (300), iodine (150), manganese (200), zinc (300) and selenium (10).
6Regumaize 44 (SvG Intermol Ltd, Bootle, Merseyside, UK) declared composition (g/kg DM) as containing CP (440), water-soluble carbohydrates (550), ME 11.8 MJ/kg DM.
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neutral detergent fibre, organic matter, crude protein (CP),
water-soluble carbohydrates, ether extract, starch, metaboli-
sable energy and FA determinations according to procedures
described elsewhere by Kliem et al. (2008).
Milk yields were recorded twice daily for individual ani-
mals during the last 7 days of each experimental period.
Samples of milk preserved with potassium dichromate
(1 mg/ml; Lactabs, Thomson and Capper, Runcorn, UK) were
collected during this period and submitted for fat, CP and
lactose determinations based on infrared spectroscopy (Foss
Electric Ltd, York, UK). Additional samples of unpreserved
milk were collected during the last 24 h of each experimental
period, stored at 2208C until composited according to milk
yield and submitted for FA analysis.
Lipid in 1 ml milk and appropriate sample weight of forage,
concentrate and lipid supplements was extracted and trans-
esterified to fatty acid methyl esters (FAME) according to
standard methods (Kliem et al., 2008). The distribution of
conjugated linoleic acid (CLA) isomers in milk FAME was
determined by HPLC using four silver impregnated silica
columns (ChromSpher 5 Lipids, 2503 4.6 mm; 5mm particle
size, Varian Ltd, Oxford, UK) coupled in series using 0.1% (v/v)
of acetonitrile in heptane as the mobile phase (Shingfield
et al., 2003). Isomers were identified using an authentic CLA
methyl ester standard (O-5632, Sigma-Aldrich, YA-Kemia
Limited, Helsinki, Finland) and chemically synthesised trans-9,
cis-11 CLA (Shingfield et al., 2005). Identification was verified
using cis-9, trans-11 CLA as a landmark isomer.
Milk FA composition was expressed as a weight percentage
of total FAs using response factors derived from the analysis
of a butter oil reference standard (CRM 164; Community
Bureau of Reference, Brussels, Belgium). Concentrations of
specific conjugated isomers in milk fat were calculated based
on proportionate peak area responses determined by HPLC
and the sum of trans-7, cis-9 CLA, trans-8, cis-10 CLA and
cis-9, trans-11 CLA weight percentage determined as a single
peak by gas chromatography.
Statistical analysis
Intake, milk production and milk FA composition data were
analysed using a general linear model with effects for cow,
period and treatment (Statistical Analysis Systems software
package version 8.2, SAS Institute, Cary, NC, USA). Treatment
carry-over effects were also included in the statistical model
but were removed when declared non significant (P, 0.10).
Preplanned contrasts included (i) CPO v. COR1, (ii) CPO v.
HOR1, (iii) linear component of the response to incremental
amounts of milled conventional rapeseeds in the diet, (iv) lin-
ear component of the response to incremental amounts of
milled high oleic acid rapeseeds in the diet and (v) comparison
of mean responses to milled conventional and high oleic acid
rapeseeds in the diet. Single degree of freedom contrasts were
also included in the statistical model to test for the significance
of non-linear (quadratic) components of the response to
incremental amounts of both types of milled rapeseed sup-
plements in the diet. Least square means are reported and
treatment effects were considered significant at P, 0.05.
Results
Analysis of the milled rapeseed/wheat supplements confirmed
the higher cis-9 18:1 content of HOR compared with COR (68
and 57 g/100 g FAs, respectively). Lipid derived from the COR
supplement compared with the HOR supplement contained
16:0 (5 v. 4 g/100 g FAs), 18:0 (2 v. 2 g/100 g FAs), 18:2n-6 (20
v. 16 g/100 g FAs) and 18:3n-3 (8 v. 2 g/100 g FAs). The higher
enrichment of cis-9 18:1 in HOR was therefore associated with
a lower sum of 18:2n-6 and 18:3n-3 relative to COR (18 v.
29 g/100 g FAs). The total FA content of the COR and HOR
supplements were 230 and 236 g/kg DM, respectively.
By design, all seven experimental diets were of similar
chemical composition. However, total dietary FA content was
increased with incremental inclusion of milled rapeseeds
(Table 1). The predominant FA in the CPO diet was 16:0
contributing to more than one-third of total FAs, whereas
cis-9 18:1 was the major dietary FA for all other treatments.
For each inclusion level, the amount of cis-9 18:1 in the diet
was approximately 5 g/kg DM higher on the HOR than COR
treatments. Increasing inclusion level of rapeseed also
increased dietary 18:2n-6 and 18:3n-3 content, but the total
amount of PUFA at each level of inclusion was consistently
higher for COR than HOR treatments.
There was no effect (P. 0.05) of replacing CPO with
milled rapeseeds on DM intake, milk yield, milk constituent
content or output (Table 3). FA intake varied in direct relation
to milled rapeseed inclusion, with both varieties resulting
in lower (P, 0.001) intake of 16:0 and 18:0 and higher
(P, 0.001) intake of cis-9 18:1, 18:2n-6 and 18:3n-3 than
the CPO diet. Intake of cis-9 18:1, 18:2n-6 and 18:3n-3
increased linearly (P, 0.001) with incremental milled rape-
seed inclusion. Consumption of cis-9 18:1 was on average
117 g/day higher (P, 0.001) for cows fed HOR than COR
treatments, whereas ingestion of PUFA was higher (P, 0.001)
by cows fed the COR than HOR diets.
Replacing CPO with both rapeseed supplements altered
milk FA composition changes that were characterised as a
decrease (P, 0.01) in total SFA, mainly due to lowered
(P, 0.001) 16:0 concentrations, and an increase (P, 0.05) in
total cis- and trans-16:1, total 18:1 and total trans FA content
(Table 4). Furthermore, supplements of milled rapeseeds also
resulted in a decrease (P, 0.001) in cis-9 16:1, 18:2n-6, trans-
8, cis-10 CLA and trans-9, trans-11 CLA and an increase
(P, 0.01) in 18:0, 20:0, cis-9 and -11 20:1 (Table 4), cis (D9,
13 and 16) and trans (D6 to D9, 12 and 16) 18:1 (Table 5),
cis-9, trans-13 18:2 and trans-10, trans-15 18:2 (Table 6).
Relative to the CPO treatment, the COR1 treatment resulted in
specific changes in 13:0, 14:0, 18:3n-3, cis-12 18:1, trans-13,
-14 18:1, cis-9, cis-15 18:2 and trans-10, cis-12 CLA con-
centrations, whereas the HOR1 diet increased (P, 0.01) milk
trans-4 and trans-5 18:1 content compared with CPO (Table 5).
Incremental inclusion of milled rapeseeds in the diet
resulted in linear (P, 0.05) decreases in total short- and
medium-chain SFA with between 4 and 14 carbon atoms,
16:0 and total SFA and elicited linear (P, 0.05) increases
in 18:0, cis-9 18:1 and total cis- MUFA concentrations.
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The decrease in milk fat 8:0 and trans-9 14:1 content was also
non-linear (P, 0.05). Linear responses (P, 0.05) to incre-
mental amounts of milled HOR were also observed for milk fat
trans-16:1 (Table 4), trans-4, -9 and -10 18:1 (Table 5), 18:2n-6,
cis-9, cis-15 18:2 and trans-9, cis-12 18:2 (Table 6), several
isomers of CLA (Table 6) and 18:3n-3 (Table 4) concentrations.
The type of rapeseed in the diet also influenced milk FA
composition. Milk from cows fed milled CORs contained
higher (P, 0.05) 14:0, 16:0, 18:3n-3, <C14 FAs, total SFA
(Table 4), cis-12 18:1 (Table 5) and specific 18:2 isomers
including 18:2n-6 and cis-9, cis-15 18:2 (Table 6) compared
with milled HORs. In contrast, HOR treatments resulted in
higher (P, 0.05) mean milk fat 18:0, 20:0, cis-20:1, cis-9
18:1, trans-4 18:1, trans-5 18:1 and trans-6-8 18:1 contents
than the COR treatments. Increases in the 18:3n-3 content of
milk from cows fed the COR diet resulted in a lower
(P, 0.05) n-6 : n-3 ratio than the control and HOR treat-
ments supplying the same amount of rapeseed oil.
Discussion
This experiment examined the effects of replacing CPO with
incremental amounts of two varieties of milled rapeseeds on
milk production and milk FA composition in high-yielding
dairy cows fed a maize silage-based diet. Supplements of
milled high oleic acid rapeseed and wheat contained lower
concentrations of cis-9 18:1 relative to milled conventional
rapeseed and wheat than anticipated. Previous studies have
examined the effects of a rapeseed oil, which contained 77 g
cis-9 18:1/100 g FAs in lactating cows (Jenkins, 1998; Loor
et al. 2002), whereas the cis-9 18:1 content of oil from high
oleic acid mutants can vary from 70% to 81% total FAs
(Schierholt et al., 2000). No measurements of the lipid
composition of whole rapeseeds were made in this study, but
the oil of the ‘Nexera’ high oleic acid rapeseed variety typi-
cally contains 73 g cis-9 18:1 and 17 g of PUFA/100 g total
FAs (Dow AgroSciences LLC).
Including both types of rapeseed in the diet even at the
highest inclusion level supplying in excess of 1100 g oil/day
had no significant effect on DM intake, milk yield or milk
constituent composition compared with the CPO diet, with
the exception of a marginal decrease in milk fat concentra-
tions. Previous studies have shown that supplementing the
diet with supplements providing 1000 g rapeseed oil/day
have no significant impact on DM intake and milk yield
of cows when compared with a control diet, (Chelikani
et al., 2004; Givens et al., 2009), but may, depending on the
composition of the basal diet, lower milk fat synthesis
(Chelikani et al., 2004). However, supplementing the diet
with 1214 g/day of rapeseed oil in the form of whole cracked
rapeseeds was shown to decrease DM intake, milk yield and
fat yield in mid-lactation cows (Givens et al., 2003). It is
generally accepted that high levels of plant oils or oilseeds in
the diet induce adverse effects on rumen function and cow
performance (Palmquist, 1994; Lock and Shingfield, 2004).
Results from this study as well as earlier studies highlight
that a form of lipid in the diet is an important determinant
of the potential effects on intake and milk production.
Table 3 Effect of replacing CPO with incremental amounts of milled conventional or high oleic acid rapeseeds on DM and fatty acid intake, milk yield
and composition
Treatments1 P -
CPO COR1 COR2 COR3 HOR1 HOR2 HOR3 s.e.m.-
-
1 2 3 4 5
DM intake (kg/day) 23.7 24.2 24.5 23.6 24.7 24.2 23.6 0.53 ns ns ns ns ns
Fatty acid intake (g/day)
16:0 387 91.4 103 108 90.0 91.6 98.8 8.22 *** *** ns ns ns
18:0 36.7 19.5 23.3 26.2 20.1 23.0 25.9 0.74 *** *** *** *** ns
18:1 cis-9 344 477 602 694 583 720 822 13.4 *** *** *** *** ***
18:2n-6 243 314 347 374 290 306 325 6.8 *** *** *** ** ***
18:3n-3 43.0 101 117 131 57.3 58.6 62.2 2.44 *** *** *** ns ***
Yield
Milk (kg/day) 41.2 40.9 41.0 41.7 41.3 41.6 41.5 1.01 ns ns ns ns ns
Fat (g/day) 1540 1490 1439 1451 1487 1450 1460 54.7 ns ns ns ns ns
Protein (g/day) 1232 1246 1285 1229 1245 1280 1256 41.0 ns ns ns ns ns
Lactose (g/day) 1845 1897 1917 1889 1912 1926 1944 66.0 ns ns ns ns ns
Concentration (g/kg)
Fat 37.2 36.3 34.9 34.7 36.0 34.6 35.1 0.88 ns ns ns ns ns
Protein 30.0 30.5 31.6 29.4 30.0 30.8 30.2 0.69 ns ns ns ns ns
Lactose 44.7 46.3 46.6 45.3 46.4 46.3 46.8 0.68 ns ns ns ns ns
CPO5 calcium salts of palm oil distillate-based diet; COR1, COR2 and COR35 conventional oleic acid rapeseed at three inclusion levels; HOR1, HOR2 and
HOR35 high oleic acid rapeseed at three inclusion levels; DM5 dry matter.
-Refers to the significance of five preplanned comparisons; 1 – CPO diet compared with 73 g/kg of milled COR; 2 – CPO diet compared with 73 g/kg of milled
HORs; 3 – linear component of the response to incremental amounts of milled CORs in the diet; 4 – linear component of the response to incremental amounts of
milled HORs in the diet; 5 – comparison of mean responses to milled COR and HOR in the diet. *, ** and ***P, 0.05, P, 0.01 and P, 0.001, respectively.
-
-
s.e.m. for n5 35 measurements, 13 error d.f.
11, 2 and 3, refers to rapeseed inclusion levels of 73, 96 and 118 g/kg DM, respectively.
Rapeseed oleic acid content and milk fatty acids
1315
https://doi.org/10.1017/S1751731111000310
Downloaded from https:/www.cambridge.org/core. Open University Library, on 21 Jan 2017 at 08:01:09, subject to the Cambridge Core terms of use, available at https:/www.cambridge.org/core/terms.
Table 4 Effect of replacing CPO with incremental amounts of milled conventional or high oleic acid rapeseeds on milk fatty acid composition (g/100 g fatty acids)
Treatments1 P -
CPO COR1 COR2 COR3 HOR1 HOR2 HOR3 s.e.m.-
-
1 2 3 4 5
4:0 3.5 3.2 3.0 3.2 3.3 2.8 2.9 0.19 ns ns ns ns ns
6:0 2.4 2.4 2.3 2.2 2.4 2.3 1.9 0.07 ns ns * *** ns
8:0 1.2 1.3 1.2 1.1 1.2 1.2 0.9 0.04 ns ns ** *** *
10:0 2.4 2.6 2.5 2.1 2.4 2.4 1.9 0.11 ns ns ** ** ns
10:1 cis-9 0.25 0.29 0.26 0.23 0.27 0.24 0.19 0.014 ns ns * ** *
12:0 2.5 2.9 2.7 2.3 2.6 2.6 2.1 0.13 ns ns ** ** ns
13:02 0.11 0.16 0.15 0.13 0.15 0.14 0.12 0.014 * ns ns ns ns
13:0 anteiso 0.02 0.03 0.03 0.03 0.03 0.03 0.03 0.003 ns ns ns ns ns
14:0 9.2 10.3 9.9 8.8 9.7 9.2 8.3 0.25 ** ns *** ** *
14:0 iso 0.09 0.10 0.11 0.09 0.10 0.08 0.08 0.014 ns ns ns ns ns
14:1 cis-9 0.80 0.97 0.92 0.82 0.90 0.81 0.80 0.052 * ns * ns ns
14:1 trans-9 0.19 0.19 0.19 0.19 0.19 0.19 0.17 0.003 ns ns ns ** *
15:0 0.74 0.85 0.82 0.77 0.89 0.81 0.79 0.046 ns * ns ns ns
15:0 anteiso 0.37 0.39 0.41 0.38 0.41 0.40 0.36 0.010 ns * ns ** ns
16:0 33.7 24.3 21.2 20.2 21.9 20.0 19.2 0.51 *** *** *** ** **
16:0 iso 0.24 0.22 0.27 0.20 0.24 0.23 0.21 0.020 ns ns ns ns ns
16:1 cis-93 1.27 0.99 0.90 0.88 0.93 0.81 0.89 0.041 *** *** ns ns ns
16:1 cis-11 0.002 0.010 0.019 0.010 0.008 0.013 0.017 0.006 ns ns ns ns ns
16:1 cis-13 0.01 0.02 0.02 0.02 0.02 0.02 0.02 0.004 ns ns ns ns ns
16:1 trans-6/7/8 0.04 0.04 0.05 0.05 0.06 0.05 0.06 0.005 ns * ns ns ns
16:1 trans-94 0.27 0.30 0.32 0.32 0.28 0.30 0.32 0.014 ns ns ns * ns
16:1 trans-10 0.000 0.009 0.004 0.007 0.002 0.012 0.005 0.003 ns ns ns ns ns
16:1 trans-11 0.02 0.04 0.04 0.04 0.03 0.03 0.04 0.003 ns ns ns * ns
16:1 trans-12 0.17 0.14 0.14 0.15 0.14 0.15 0.16 0.005 ns ns ns ** ns
16:1 trans-13 0.34 0.37 0.40 0.35 0.37 0.36 0.33 0.012 ns ns ns ns ns
17:0 0.40 0.43 0.43 0.41 0.41 0.41 0.39 0.012 ns ns ns ns ns
17:1 cis-9 0.13 0.15 0.14 0.14 0.14 0.13 0.14 0.007 ns ns ns ns ns
18:0 iso 0.03 0.02 0.02 0.01 0.02 0.01 0.01 0.005 ns ns ns ns ns
18:0 9.1 13.3 15.2 16.1 14.8 17.0 16.7 0.55 *** *** ** * *
18:1 trans total 3.3 4.8 5.2 5.7 4.9 5.1 5.9 0.40 * * ns ns ns
18:1 cis total 22.2 24.5 26.5 28.5 26.7 27.6 30.6 0.45 ** *** *** *** ***
Non-CLA5 18:2 total 3.0 2.7 2.6 2.5 2.5 2.3 2.3 0.08 * *** ns ns **
CLA total 0.59 0.62 0.67 0.72 0.59 0.63 0.63 0.038 ns ns ns ns ns
18:3n-3 0.23 0.29 0.29 0.28 0.22 0.19 0.17 0.014 * ns ns * ***
19:06 0.04 0.05 0.05 0.05 0.05 0.06 0.05 0.005 ns ns ns ns ns
20:0 0.11 0.20 0.23 0.24 0.23 0.26 0.26 0.007 *** *** *** * ***
20:1 cis-5 0.01 0.01 0.02 0.02 0.01 0.02 0.02 0.003 ns ns ns ns ns
20:1 cis-9 0.10 0.18 0.21 0.22 0.21 0.22 0.25 0.006 *** *** *** ** ***
20:1 cis-11 0.05 0.09 0.10 0.10 0.11 0.11 0.13 0.008 ** *** ns ns *
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Table 4 Continued
Treatments1 P -
CPO COR1 COR2 COR3 HOR1 HOR2 HOR3 s.e.m.-
-
1 2 3 4 5
20:2n-6 0.04 0.03 0.02 0.03 0.03 0.03 0.02 0.004 * * ns ns ns
20:3n-3 0.001 0.007 0.011 0.011 0.043 0.046 0.051 0.004 ns *** ns ns ***
20:3n-6 0.03 0.05 0.05 0.04 0.05 0.06 0.06 0.006 * * ns ns *
20:5n-3 0.03 0.03 0.02 0.02 0.02 0.02 0.01 0.003 ns * ns ns **
22:0 0.02 0.02 0.02 0.01 0.01 0.02 0.003 0.003 ns ns ns * ns
22:1 cis-13 0.11 0.09 0.08 0.07 0.08 0.08 0.07 0.005 * ** * ns ns
22:2n-6 0.03 0.02 0.03 0.03 0.03 0.02 0.01 0.003 ns ns ns ** *
22:4n-6 0.009 0.02 0.02 0.01 0.01 0.01 0.002 0.004 ns ns ns * ns
22:5n-3 0.04 0.04 0.04 0.03 0.03 0.04 0.02 0.006 ns ns ns ns ns
24:0 0.01 0.01 0.02 0.02 0.02 0.02 0.01 0.003 ns ** ns * ns
S< 14:0 21.5 23.2 22.1 19.9 22.0 20.9 18.3 0.57 ns ns *** *** *
S saturates 66.5 63.3 61.0 58.5 61.2 60.4 56.6 0.55 ** *** *** *** **
S cis MUFA 24.9 27.4 29.4 31.2 29.4 30.1 33.2 0.46 ** *** *** *** **
S trans MUFA 4.2 5.8 6.2 6.7 5.8 6.0 6.9 0.41 * * ns ns ns
S trans total 5.3 7.2 7.6 8.1 7.1 7.3 8.2 0.43 ** * ns ns ns
n-6 : n-3 PUFA 9.1 5.9 5.7 5.8 6.2 6.1 6.7 0.18 *** *** ns ns **
Total fatty acids (g/100 g milk fat) 94.4 94.5 94.6 94.6 94.5 94.3 94.4 0.11 ns Ns ns ns ns
CPO5 calcium salts of palm oil distillate-based diet, COR1, COR2 and COR35 conventional oleic acid rapeseed at three inclusion levels, HOR1, HOR2 and HOR35 high oleic acid rapeseed at three inclusion levels;
CLA5 conjugated linoleic acid; MUFA5monounsaturated fatty acids; PUFA5 polyunsaturated fatty acids; DM5 dry matter.
-Refers to the significance of five comparisons; 1 – CPO diet v. COR diet level 1; 2 – CPO v. HOR diet level 1; 3 – linear response to COR inclusion level; 4 – linear response to HOR inclusion level; 5 – average of COR diet
responses v. average of HOR responses. *, ** and ***P, 0.05, P, 0.01 and P, 0.001, respectively.
-
-
s.e.m. for n5 35 measurements, 13 error d.f.
11, 2 and 3, refers to rapeseed inclusion levels of 73, 96 and 118 g/kg DM, respectively.
2Co-elutes with cis-9 12:1 as a minor isomer.
3Co-elutes with 17:0 anteiso.
4Co-elutes with 17:0 iso.
5All 18:2 isomers excluding CLA.
6Co-elutes with cis-15 18:1.
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Table 5 Effect of replacing CPO with incremental amounts of milled conventional or high oleic acid rapeseeds on milk 18:1 isomer composition
(g/100 g fatty acids)
Treatments1 P -
CPO COR1 COR2 COR3 HOR1 HOR2 HOR3 s.e.m.-
-
1 2 3 4 5
cis-9 18:12 21.1 22.7 24.8 26.9 25.1 26.1 28.9 0.44 * *** *** *** ***
cis-11 18:1 0.59 0.65 0.63 0.69 0.69 0.66 0.74 0.031 ns ns ns ns ns
cis-12 18:1 0.25 0.33 0.28 0.28 0.29 0.24 0.23 0.015 ** ns * * **
cis-13 18:1 0.07 0.10 0.10 0.10 0.10 0.10 0.11 0.006 * ** ns ns ns
cis-16 18:1 0.09 0.11 0.12 0.11 0.11 0.11 0.11 0.005 * ** ns ns ns
trans-4 18:1 0.04 0.04 0.05 0.05 0.05 0.06 0.07 0.004 ns ** ns * **
trans-5 18:1 0.03 0.04 0.04 0.05 0.05 0.05 0.05 0.003 ns *** ns ns ***
trans-6,-7,-8 18:1 0.37 0.59 0.65 0.76 0.72 0.77 0.85 0.052 * *** * ns *
trans-9 18:1 0.31 0.48 0.51 0.55 0.52 0.53 0.66 0.036 ** ** ns * ns
trans-10 18:1 0.37 0.76 0.89 1.00 0.64 0.69 1.3 0.210 ns ns ns * ns
trans-11 18:1 0.95 1.13 1.25 1.31 1.04 1.26 1.12 0.068 ns ns ns ns ns
trans-12 18:1 0.37 0.56 0.59 0.64 0.62 0.62 0.62 0.039 ** *** ns ns ns
trans-13,-14 18:1 0.72 1.00 0.96 1.10 1.03 0.88 1.06 0.068 ** ns ns ns **
trans-16 18:13 0.28 0.44 0.45 0.48 0.43 0.44 0.47 0.016 *** *** ns ns ns
CPO5 calcium salts of palm oil distillate-based diet, COR1, COR2 and COR35 conventional oleic acid rapeseed at three inclusion levels, HOR1, HOR2 and
HOR35 high oleic acid rapeseed at three inclusion levels; DM5 dry matter.
-Refers to the significance of five comparisons; 1 – CPO diet v. COR diet level 1; 2 – CPO diet v. HOR diet level 1; 3 – linear response to COR inclusion level; 4 – linear
response to HOR inclusion level; 5 – average of COR diet responses v. average of HOR responses. *, ** and ***P, 0.05, P, 0.01 and P, 0.001, respectively.
-
-
s.e.m. for n5 35 measurements, 13 error d.f.
11, 2 and 3, refers to rapeseed inclusion levels of 73, 96 and 118 g/kg DM, respectively.
2Co-elutes with cis-10 18:1 as a minor isomer.
3Co-elutes with cis-14 18:1.
Table 6 Effect of replacing CPO with incremental amounts of milled conventional or high oleic acid rapeseeds on milk 18:2 isomer composition
(mg/100 g fatty acids)
Treatments1 P -
CPO COR1 COR2 COR3 HOR1 HOR2 HOR3 s.e.m.-
-
1 2 3 4 5
cis-9, cis-12 18:2 2563 1970 1869 1817 1850 1671 1605 74.8 *** *** ns * *
cis-9, cis-15 18:2 10.7 23.2 23.2 22.5 13.6 10.6 4.4 2.11 ** ns ns ** ***
cis-9, trans-12 18:2 88.5 106.3 99.0 72.6 118.3 75.5 67.0 13.31 ns ns ns * ns
cis-9, trans-13 18:2 181 299 300 326 285 256 315 16.3 *** *** ns ns ns
trans-9, cis-12 18:2 22.8 16.1 13.5 8.6 12.7 4.0 0.0 3.85 ns ns ns * *
trans-11, cis-15 18:2 68.4 103.8 121.0 113.8 60.6 52.5 67.3 13.20 ns ns ns ns **
trans-10, trans-15 18:2 94.2 144.5 151.2 156.6 131.9 131.6 158.2 7.94 *** ** ns * ns
trans-11, trans-15 18:2 34.6 51.4 44.1 46.7 30.7 36.7 45.2 8.64 ns ns ns ns ns
trans-13, trans-15 CLA 0.81 1.2 1.1 1.1 1.5 0.97 0.54 0.447 ns ns ns ns ns
trans-12, trans-14 CLA 5.3 8.0 6.9 7.7 5.9 4.6 4.2 1.11 ns ns ns ns **
trans-11, trans-13 CLA 13.5 15.6 15.8 18.4 12.0 7.9 9.8 1.92 ns ns ns ns ***
trans-10, trans-12 CLA 9.2 6.7 6.6 7.0 7.8 6.5 6.3 0.91 * ns ns ns ns
trans-9, trans-11 CLA 21.5 15.1 14.9 14.8 16.0 13.6 11.8 1.36 ** ** ns * ns
trans-8, trans-10 CLA 12.6 2.3 3.6 3.5 4.1 4.4 3.2 0.89 *** *** ns ns ns
trans-7, trans-9 CLA 3.7 2.8 3.6 3.5 3.7 4.5 4.1 0.68 ns ns ns ns ns
trans-12, cis-14 CLA 4.3 5.9 4.1 4.8 4.5 1.8 2.4 1.07 ns ns ns ns *
trans-11, cis-13 CLA 6.7 5.5 4.7 5.2 5.5 5.0 2.6 1.09 ns ns ns * ns
cis-11, trans-13 CLA 1.90 1.50 1.64 1.46 2.11 1.13 0.82 0.483 ns ns ns * ns
trans-10, cis-12 CLA 12.6 7.2 8.5 8.1 7.0 4.6 11.0 3.16 ns ns ns ns ns
cis-9, trans-11 CLA 597 580 658 707 570 642 610 49.8 ns ns * ns ns
trans-9, cis-11 CLA 15.6 17.3 23.9 23.8 18.6 18.6 36.4 7.51 ns ns ns * ns
trans-8, cis-10 CLA 5.1 5.4 5.4 4.6 4.3 5.7 7.6 1.23 ns ns ns * ns
trans-7, cis-9 CLA 62.1 126 141 162 144 144 206 24.4 ns2 ** ns * ns
CPO5 calcium salts of palm oil distillate; COR1, COR2 and COR35 conventional oleic acid rapeseed at three inclusion levels; HOR1, HOR2 and HOR 35 high oleic
acid rapeseed at three inclusion levels; DM5 dry matter.
-Refers to the significance of five comparisons; 1 – CPO diet v. COR diet level 1; 2 – CPO diet v. HOR diet level 1; 3 – linear response to COR inclusion level; 4 – linear
response to HOR inclusion level; 5 – average of COR diet responses v. average of HOR responses. *, ** and *** P, 0.05, P, 0.01 and P, 0.001, respectively.
-
-
s.e.m. for n5 35 measurements, 13 error d.f.
11, 2 and 3, refers to rapeseed inclusion levels of 73, 96 and 118 g/kg DM, respectively.
2P5 0.05.
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Ground rapeseeds have been shown to reduce fat corrected
milk yield, milk fat and protein content in the absence of
changes in DM intake (Chichlowski et al., 2005). However,
supplements of milled rapeseeds and wheat were reported to
stimulate higher DM intake compared with the same amount
of lipid in the diet as rapeseed oil (Givens et al., 2009). Overall,
available data suggest that inclusion of milled rapeseeds in
the diet minimises potential negative effects of rapeseed oil
on rumen function and animal performance.
Replacing CPO with both rapeseed varieties resulted in a
decrease in milk fat 16:0 and total SFA content. This is partially
due to the presence of a palm oil-based rumen-protected lipid
supplement in the CPO ration that was used to ensure that
treatments were isoenergetic. However, earlier studies have
shown that compared with a diet control containing no addi-
tional lipid, rapeseed oil lowers milk fat 16:0 and total SFA
concentrations (Collomb et al., 2004; Ryha¨nen et al., 2005;
Rego et al., 2009), indicating that irrespective of the composi-
tion of the basal diet, rapeseed-based lipid supplements can be
expected to decrease milk SFA content. Rapeseed oil in the diet
leads to an increase in long-chain unsaturated FAs available for
absorption in the small intestine of lactating cows (Loor et al.,
2002) leading to an inhibition of FA synthesis de novo in the
mammary gland (Chilliard et al., 2000). In this study, rapeseed
inclusion did not appear to affect other short- and medium-
chain SFA concentrations, although the COR1 treatment
increased milk fat 14:0 content compared with the CPO diet.
Incremental inclusion of rapeseeds in the diet resulted in a
linear decrease in milk SFA concentrations, 16:0 in particular,
with no evidence that the changes in milk FA composition
reached a plateau under the specified conditions of this
experiment. Furthermore, marginal decreases in milk SFA
content were greater for the HOR compared with the COR
rapeseed with HOR treatments resulting in lower milk fat
concentrations of SFA synthesised de novo and higher 18:0
concentrations. It is probable that the differences in the extent
of changes in milk SFA due to rapeseed variety is at least in
part due to a concentration effect, as HOR treatments induced
a higher enrichment of cis-9 18:1. It is also possible that the
larger decreases in milk SFA concentration following HOR
rapeseed supplementation reflects direct competition between
cis-9 18:1 and newly synthesised SFA for esterification with
glycerol at the sn-2 and sn-3 during mammary triacylglycerol
synthesis (Hansen and Knudsen, 1987).
Despite diets containing rapeseeds resulting in a lower
18:0 intake than the CPO diet, both COR and HOR treatments
enhanced milk fat 18:0 concentration. This can be explained
by rapeseed diets resulting in a higher 18-carbon unsaturated
FA intake than the CPO diet, which, following complete
hydrogenation in the rumen (Harfoot and Hazlewood, 1997)
increases the availability of 18:0 for absorption in the bovine
small intestine. Post-ruminal flow of 18:0 has been found to
be approximately 11 times greater than intake (on a g/day
basis) in lactating cows fed diets containing rapeseed oil
(Loor et al., 2002). An increase in milk 18:0 concentrations is
a typical response to dietary rapeseed supplements (Givens
and Shingfield, 2006; Glasser et al., 2008).
Replacing CPO with rapeseed enhanced cis-MUFA in milk
fat. The second most abundant cis-MUFA, cis-9 16:1, had
a lower concentration in milk fat from cows consuming
rapeseed diets when compared with the CPO diet, which is
in agreement with earlier studies examining the effect of
rapeseed in the diet in lactating cows (DePeters et al., 2001;
Collomb et al., 2004). A lower concentration of cis-9 16:1
can be attributed to decreased supply of 16:0 available for
conversion to cis-9 16:1 via the action of D9-desaturase in
the mammary gland. Use of 13C-labelled FA substrates
indicate that around 50% cis-9 16:1 secreted in milk is syn-
thesised endogenously via the action of D9-desaturase on
16:0 (Mosley and McGuire, 2007).
Enhanced cis-MUFA concentration in milk fat from all of
the rapeseed diets was primarily due to increases in cis-9
18:1 concentration. This can be explained by an increased
intake of cis-9 18:1, and also due to increased mammary
availability of 18:0, which is desaturated at the mammary gland
level. Around 50% of 18:0 taken up by the mammary gland is
desaturated (Enjalbert et al., 1998), and all studies examin-
ing responses to supplemental rapeseeds or rapeseed oil in
the diet report an increase in milk cis-9 18:1 concentration
(Givens and Shingfield, 2006; Glasser et al., 2008). Increases
in milk fat cis-9 18:1 concentrations to both rapeseeds were
linear across the range of supplements fed in this experiment,
indicating the potential to further enhance milk cis-9 18:1
content. Rapeseed inclusion also increased the concentration
of several other cis-18:1 (D13 and 16) isomers. It is probable
that these FAs originate from the rumen as a result of
incomplete biohydrogenation of 18:3n-3 contained in rape-
seeds (Jouany et al., 2007).
Addition of both rapeseed types to the diet resulted in
numerical increases in milk trans-16:1 and trans-18:1 con-
tent compared with the CPO diet. All rapeseed diets resulted
in significant increases in cis-9 18:1, 18:2n-6 and 18:3n-3
intake when compared with the CPO diet, but there was no
significant increase in milk fat trans-11 18:1 concentration,
the major trans FA in milk fat that is a common intermediate
formed during the penultimate step of PUFA biohydrogena-
tion in the rumen (Harfoot and Hazlewood, 1997; Shingfield
et al., 2010). A lack of change in milk fat trans-11 18:1
content has been reported in cows fed milled rapeseeds even
when a similar amount of lipid in the form of rapeseed oil
enhanced the concentration of this biohydrogenation inter-
mediate in milk (Givens et al., 2009). Previous studies have
also reported that ground rapeseeds have no effect (Collomb
et al., 2004) or result in marginal increases in milk fat trans-11
18:1 concentrations (Chichlowski et al., 2005).
In spite of cows consuming more PUFA on the COR
than HOR treatments, there was no significant difference
between rapeseed types with respect to trans-MUFA or total
trans FAs in milk indicating that biohydrogenation of cis-9
18:1 as well as 18:2n-6 and 18:3n-3 in the rumen results in
the formation and accumulation of substantial amounts
of trans FAs that are incorporated into milk fat. Total trans-
MUFA secretion in milk was more closely associated with
cis-9 18:1 intake (R25 0.785; y5 0.05x1 45.83) than with
Rapeseed oleic acid content and milk fatty acids
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PUFA intake (R25 0.528; y5 0.09x1 40.60). In vitro studies
have shown that cis-9 18:1 is converted to a range of
trans 18:1 isomers during incubation with rumen-derived
microorganisms (Mosley et al., 2002; McKain et al., 2010). In
particular, around 70% to 100% of trans-7, trans-9, trans-10
and trans-12 18:1 were thought to originate from the iso-
merisation of cis-9 18:1 (Mosley et al., 2002). Furthermore,
trans-9 18:1 can be further isomerised during incubations with
mixed rumen bacteria to yield a range of positional trans 18:1
isomers (Proell et al., 2002). Supplying higher amounts of
cis-9 18:1 in the diet in the form of the HOR supplement in this
study resulted in a higher enrichment of trans-4, trans-5 and
trans-6-8 18:1 in milk fat, and a numerical but non-significant
(P5 0.09) enrichment of milk trans-9 18:1 content compared
with the COR diet. Earlier studies also reported a significant
increase in milk trans-6-8, trans-9 18:1, trans-12, trans-13-14
and trans-16 18:1 in cows fed when rapeseed supplements
were fed compared with a control diet (Collomb et al., 2004;
Givens et al., 2009).
Trans-7, cis-9 CLA is the second most abundant CLA isomer
in bovine milk fat on most diets (Shingfield et al., 2008), that
is synthesised exclusively via the action of D9 desaturase on
trans-7 18:1 in ruminant tissues (Corl et al., 2002; Piperova
et al., 2002). Enhanced concentrations of this isomer in milk
fat following replacement of CPO with milled rapeseeds can
be attributed to an increased availability of trans-7 18:1 at the
mammary gland, following the formation of this intermediate
during biohydrogenation of cis-9 18:1 in the rumen (Mosley
et al., 2002). Consistent with products formed during incu-
bations of cis-9 18:1 with mixed rumen bacteria (Mosley et al.,
2002), HOR enhanced milk fat trans-6-8 18:1 content and
resulted in numerically higher concentrations of trans-7, cis-9
CLA compared with COR treatments.
Milk fat cis-9, trans-13 18:2 content was substantially
enhanced when rapeseed lipids replaced CPO in the diet. This
FA is at least partially synthesised endogenously in the
mammary gland via the action of D9-desaturase on trans-13
18:1 formed in the rumen (Shingfield et al., 2008). Both trans-13
18:1 and cis-9, trans-13 18:2 tend to increase following
the feeding of 18:2n-6 or 18:3n-3 – rich plant oils (Collomb
et al., 2004; Shingfield et al., 2008). Including rapeseed
lipids at the expense of CPO resulted in reduced concentra-
tions of trans-8, trans-10 CLA and trans-9, trans-11 CLA in
milk. Incubations of 18:2n-6 with mixed rumen microbes
(Jouany et al., 2007), measurements of FA flows at the
omasum (Shingfield et al., 2008) and milk FA composition in
cows fed plant oils (Shingfield et al., 2008; Rego et al., 2009)
indicate that trans-8, trans-10 CLA and trans-9, trans-11 CLA
accumulate in the rumen in direct relation to 18:2n-6 intake.
The results of this study for milk fat CLA isomer concentra-
tions appear to be consistent with the higher 18:2n-6 intake
of cows fed diets containing milled rapeseeds than CPO.
In conclusion, replacing CPO with milled rapeseeds
at inclusion levels up to 1150 g oil/day decreased milk fat
SFA, enhanced milk cis-MUFA and increased trans FA con-
centrations without inducing adverse effects on DM intake
and milk production. Use of a HOR variety induced larger
decreases in milk fat SFA, increased (P, 0.001) the ratio of
trans-MUFA : trans-PUFA and altered the relative abundance
of specific trans FA isomers compared with isoenergetic
amounts of CORs.
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